Browsing by Keyword : Temozolomide
Showing results 1 to 12 of 12
| Pub Year | | Title | AJOU Author(s) |
| 2020 | | Association between survival and levetiracetam use in glioblastoma patients treated with temozolomide chemoradiotherapy | 노태훈 |
| 2024 | | Bevacizumab Alone Versus Bevacizumab Plus Irinotecan in Patients With Recurrent Glioblastoma: A Nationwide Population-Based Study | 김세혁, 노태훈 |
| 2020 | | Characterization of orthotopic xenograft glioblastoma models | 서해영, 한지훈 |
| 2020 | | Chemoradiation in elderly patients with glioblastoma from the multi-institutional GBM-molRPA cohort: is short-course radiotherapy enough or is it a matter of selection? | 오영택 |
| 2020 | | Concurrent and Adjuvant Temozolomide for Newly Diagnosed Grade III Gliomas without 1p/19q Co-deletion: A Randomized, Open-Label, Phase 2 Study (KNOG-1101 Study) | 김세혁 |
| 2023 | | Efficacy and safety of metformin plus low-dose temozolomide in patients with recurrent or refractory glioblastoma: a randomized, prospective, multicenter, double-blind, controlled, phase 2 trial (KNOG-1501 study) | 김세혁 |
| 2022 | | Influence of Concurrent and Adjuvant Temozolomide on Health-Related Quality of Life of Patients with Grade III Gliomas: A Secondary Analysis of a Randomized Clinical Trial (KNOG-1101 Study) | 김세혁 |
| 2018 | | Procarbazine and CCNU Chemotherapy for Recurrent Glioblastoma with MGMT Promoter Methylation | 김세혁 |
| 2017 | | The effect of cytosine deaminase-expressing mesenchymal stem cells in orthotopic glioma model of immune competent mice | VU, HAI HA, 서해영 |
| 2020 | | Tumor treating fields plus temozolomide for newly diagnosed glioblastoma: a sub-group analysis of Korean patients in the EF-14 phase 3 trial | 김세혁 |
| 2008 | | Two cases of primary CNS lymphoma treated with rituximab and temozolomide | 김효철, 박준성, 이현우, 조경기 |
| 2010 | | 원발성 중추신경계 림프종에 대한 임상적 경험 | 김세혁, 김효철, 안영환, 이현우, 조경기 |
1
